End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
73.3 TWD | -0.41% | +2.81% | -3.04% |
May. 15 | Polaris Group Voluntarily Withdraws the Phase III Clinical Trial Protocol for Liver Cancer from the FDA | CI |
May. 14 | Polaris Group Announces Change of the Member of Compensation Committee | CI |
Chart calendar Polaris Group
Upcoming events on Polaris Group
Past events on Polaris Group
2024-05-13 | Q1 2024 Earnings Release |
2024-05-09 01:17 am | April 2024 Sales and Revenue Release |
2024-05-02 09:00 pm | Annual General Meeting |
2024-04-10 01:22 am | March 2024 Sales and Revenue Release |
2024-03-15 05:04 am | Q4 2023 Earnings Release |
2024-03-07 | February 2024 Sales and Revenue Release |
2024-02-06 | January 2024 Sales and Revenue Release |
2024-01-08 | December 2023 Sales and Revenue Release |
2023-12-10 10:02 pm | November 2023 Sales and Revenue Release |
2023-11-09 08:55 pm | Q3 2023 Earnings Release |
2023-11-08 08:03 pm | October 2023 Sales and Revenue Release |
2023-10-06 01:09 am | September 2023 Sales and Revenue Release |
2023-09-08 01:37 am | August 2023 Sales and Revenue Release |
2023-08-24 10:35 pm | Q2 2023 Earnings Release |
2023-08-09 | July 2023 Sales and Revenue Release |
2023-07-09 | June 2023 Sales and Revenue Release |
2023-06-11 09:00 pm | Annual General Meeting |
2023-06-09 04:16 am | May 2023 Sales and Revenue Release |
2023-06-09 03:00 am | Investor Meeting |
2023-04-16 | AACR Meeting - Clinical Trial Plenary Session |
Annual results
Fiscal Period | December | 2021 |
---|---|---|
Net sales | Released Forecast Spread | 0,00 |
EBITDA | Released Forecast Spread | 0,00 |
EBIT | Released Forecast Spread | 0,00 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 |
Net income Million TWD | Released Forecast Spread | -740 |
EPS TWD | Released Forecast Spread | -1,09 |
Announcement Date | 03/03/22 |
Quarterly results
Fiscal Period | December | 2022 Q2 |
---|---|---|
Net sales Million TWD | Released Forecast Spread | 1,77 4,00 -55.8% |
EBIT Million TWD | Released Forecast Spread | -278 -188 -47.89% |
Announcement Date | 22/08/22 |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Polaris Group
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6550 Stock
- Calendar Polaris Group